RankingsPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited
  3. Financials
  4. Net income

SymBio Pharmaceuticals Limited【JP:4582】

Market cap
¥4.4B
P/E ratio
-0.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Dec 31, 2024-3,833+95.31%
Dec 31, 2023-1,963-266.45%
Dec 31, 20221,179-41.97%
Dec 31, 20212,032-149.68%
Dec 31, 2020-4,090-6.54%
Dec 31, 2019-4,376+58.99%
Dec 31, 2018-2,753-30.80%
Dec 31, 2017-3,978+71.96%
Dec 31, 2016-2,313-12.11%
Dec 31, 2015-2,632+135.88%
Dec 31, 2014-1,116-30.48%
Dec 31, 2013-1,605-7.39%
Dec 31, 2012-1,733-17.64%
Dec 31, 2011-2,105

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)